'Breathtaking progress,' against cancer but challenges remain

June 1, 2014 by Jean-Louis Santini

Cancer researchers say major progress is being made against a malady that kills more than seven million people worldwide each year, but funding is short and many challenges remain.

Convincing people to eat healthy, exercise and quit smoking could drastically cut back on many preventable cancers, and a host of environmental factors that may lead to have yet to be solved by science, experts say.

Still, researchers gathered at the American Society of Clinical Oncology annual conference here said there is plenty of cause for optimism.

This year's event, ASCO's 50th, brings together 30,000 doctors, researchers and pharmaceutical agents from around the world.

"Scientifically the field of oncology has never been more exciting," said Clifford Hudis, president of ASCO.

He cited new targeted therapies that take aim at the cellular functions of tumors, leading to progress against some difficult to treat cancers. Also, immunotherapy is an exciting field that uses a patient's own immune system to attack tumors, and is showing promise against melanoma, leukemia, and a handful of other cancers.

"We have made incredible progress in 50 years," said Jyoti Patel, a cancer specialist at Northwestern University.

"What has been very exciting in the past several decades is the understanding of the biology of cancer, an effort of working together to catalogue the make-up and the molecular aberrations that distinguish cancer," Patel told AFP.

"In 2014 there will be almost 14 million cancer survivors in the US, and that number is expected to grow twofold over the next decades."

The death rate from cancer has dropped about 1.5 percent annually over the past decade, and a person diagnosed with cancer today has a higher than 66 percent chance of being alive in five years, according to US government statistics.

"The scientific breakthroughs in cancer are occurring at a breathtaking pace and are being translating into new drugs and devices that benefit patients more quickly than ever before," said Richard Schilsky, chief medical officer of ASCO.

However, he warned that this progress is in jeopardy due to a shortage of research funds, particularly from the National Institutes of Health, the largest government funder of US scientific research wich in 2013 had a budget of 28.9 billion dollars.

"The NIH budget has been flat for more than a decade and when adjusted for inflation... is nearly 25 percent lower today than in 2003," he said.

Hudis agreed that more government funding is needed.

"The nation's continued investment is critical if we are to make further progress against cancer and accelerated the progress already under way," said Hudis.

Risk factors

He also called for more focus on addressing both environmental and that drive up the cancer burden in the United States and around the world.

"While tobacco has long been the leading risk factor for cancer, obesity is a growing problem not only for the US but worldwide," he said.

"Obesity is overtaking tobacco, at least in the US, as the leading modifiable risk factor for multiple cancers," he said, mentioning colon and prostate cancer among the diseases susceptible to weight and eating habits.

A recent study in The Lancet found that one third of the world was overweight or obese.

"About two-thirds of cancers could be avoided if we changed our lifestyle, our diet and our sun exposure," said Patel.

She also urged more widespread vaccination against human papillomavirus (HPV) which can cause cancers of the cervix, anus, penis, head, neck and throat—as well as improved vaccination against hepatitis which can lead to liver cancer.

Smoking also remains a top cause of cancer.

"So we need better education and stricter regulations for the tobacco industry," Patel said.

Explore further: Game-changing shift occurring in cancer discovery and treatment

Related Stories

Game-changing shift occurring in cancer discovery and treatment

December 11, 2013
Research advances that have come to fruition over the past year demonstrate extraordinary progress in the fight against cancer, according to a new report released today by the American Society of Clinical Oncology (ASCO). ...

Pancreatic cancer projected to become second leading cause of cancer-related death in the US by 2030

May 20, 2014
(Medical Xpress)—An analysis projects pancreatic and liver cancers to become second and third leading causes of cancer-related death in the United States by 2030, respectively, behind lung cancer, which will remain the ...

Report sees continued advances in war against cancer

September 17, 2013
(HealthDay)—Nearly 14 million people in the United States, or one in 23, are now cancer survivors.

Radiation for prostate cancer linked to secondary cancers, study finds

May 30, 2014
Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study from the University of Michigan Comprehensive Cancer Center.

ASCO report highlights progress against cancer in last year

December 14, 2013
(HealthDay)—Progress against cancer is described in the ninth annual report of the American Society of Clinical Oncology, published online Dec. 10 in the Journal of Clinical Oncology.

Lung cancer not on many women's radar, survey finds

May 13, 2014
(HealthDay)—U.S. women still see breast cancer as a bigger killer than lung cancer, despite the fact that lung cancer kills more Americans each year—women and men—than any other cancer.

Recommended for you

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.